{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:56:29Z","timestamp":1780984589561,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073372"],"award-info":[{"award-number":["82073372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372682"],"award-info":[{"award-number":["82372682"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10009-1","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T09:58:21Z","timestamp":1775642301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting HAS2 to enhance anti-tumor immunity in pancreatic cancer via PD-L1 regulation"],"prefix":"10.1038","volume":"9","author":[{"given":"Chuifang","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2187-1967","authenticated-orcid":false,"given":"Mengjie","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanmeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunxia","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengwei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengming","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fubao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0990-9012","authenticated-orcid":false,"given":"Yanping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4740-5423","authenticated-orcid":false,"given":"Qiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-1188","authenticated-orcid":false,"given":"Daoxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"10009_CR1","doi-asserted-by":"publisher","unstructured":"Arias-Pinilla, G. A. & Modjtahedi, H. Therapeutic application of monoclonal antibodies in pancreatic cancer: advances, challenges and future opportunities. Cancers 13, https:\/\/doi.org\/10.3390\/cancers13081781 (2021).","DOI":"10.3390\/cancers13081781"},{"key":"10009_CR2","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M. & Maitra, A. Pancreatic cancer: advances and challenges. Cell 186, 1729\u20131754 (2023).","journal-title":"Cell"},{"key":"10009_CR3","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/14656566.2018.1561869","volume":"20","author":"M Diab","year":"2019","unstructured":"Diab, M., Azmi, A., Mohammad, R. & Philip, P. A. Pharmacotherapeutic strategies for treating pancreatic cancer: advances and challenges. Expert Opin. Pharmacother. 20, 535\u2013546 (2019).","journal-title":"Expert Opin. Pharmacother."},{"key":"10009_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189065","volume":"1879","author":"M Chakkera","year":"2024","unstructured":"Chakkera, M., Foote, J. B., Farran, B. & Nagaraju, G. P. Breaking the stromal barrier in pancreatic cancer: advances and challenges. Biochim. Biophys. Acta Rev. Cancer 1879, 189065 (2024).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10009_CR5","doi-asserted-by":"publisher","unstructured":"Daamen, L. A., Molenaar, I. Q. & Groot, V. P. Recent advances and future challenges in pancreatic cancer care: early detection, liquid biopsies, precision medicine and artificial intelligence. J. Clin. Med. 12, https:\/\/doi.org\/10.3390\/jcm12237485 (2023).","DOI":"10.3390\/jcm12237485"},{"key":"10009_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/cas.12913","volume":"107","author":"N Sato","year":"2016","unstructured":"Sato, N., Kohi, S., Hirata, K. & Goggins, M. Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight. Cancer Sci. 107, 569\u2013575 (2016).","journal-title":"Cancer Sci."},{"key":"10009_CR7","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.18632\/oncotarget.6617","volume":"7","author":"XB Cheng","year":"2016","unstructured":"Cheng, X. B., Kohi, S., Koga, A., Hirata, K. & Sato, N. Hyaluronan stimulates pancreatic cancer cell motility. Oncotarget 7, 4829\u20134840 (2016).","journal-title":"Oncotarget"},{"key":"10009_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91796-x","volume":"11","author":"K Tahkola","year":"2021","unstructured":"Tahkola, K. et al. Stromal hyaluronan accumulation is associated with low immune response and poor prognosis in pancreatic cancer. Sci. Rep. 11, 12216 (2021).","journal-title":"Sci. Rep."},{"key":"10009_CR9","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","volume":"62","author":"MA Jacobetz","year":"2013","unstructured":"Jacobetz, M. A. et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut 62, 112\u2013120 (2013).","journal-title":"Gut"},{"key":"10009_CR10","doi-asserted-by":"publisher","unstructured":"Kobayashi, T., Chanmee, T. & Itano, N. Hyaluronan: metabolism and function. Biomolecules 10, https:\/\/doi.org\/10.3390\/biom10111525 (2020).","DOI":"10.3390\/biom10111525"},{"key":"10009_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/15216540214929","volume":"54","author":"N Itano","year":"2002","unstructured":"Itano, N. & Kimata, K. Mammalian hyaluronan synthases. IUBMB Life 54, 195\u2013199 (2002).","journal-title":"IUBMB Life"},{"key":"10009_CR12","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1111\/febs.14847","volume":"286","author":"A Passi","year":"2019","unstructured":"Passi, A., Vigetti, D., Buraschi, S. & Iozzo, R. V. Dissecting the role of hyaluronan synthases in the tumor microenvironment. FEBS J. 286, 2937\u20132949 (2019).","journal-title":"FEBS J."},{"key":"10009_CR13","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1053\/j.gastro.2022.02.035","volume":"162","author":"VK Somani","year":"2022","unstructured":"Somani, V. K. et al. IRAK4 signaling drives resistance to checkpoint immunotherapy in pancreatic ductal adenocarcinoma. Gastroenterology 162, 2047\u20132062 (2022).","journal-title":"Gastroenterology"},{"key":"10009_CR14","doi-asserted-by":"publisher","unstructured":"Martinez-Bosch, N., Vinaixa, J. & Navarro, P. Immune evasion in pancreatic cancer: from mechanisms to therapy. Cancers 10, https:\/\/doi.org\/10.3390\/cancers10010006 (2018).","DOI":"10.3390\/cancers10010006"},{"key":"10009_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/BS9.0000000000000149","volume":"5","author":"YJ Zhou","year":"2023","unstructured":"Zhou, Y. J. et al. PD-L1: expression regulation. Blood Sci. 5, 77\u201391 (2023).","journal-title":"Blood Sci."},{"key":"10009_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00262-015-1783-4","volume":"65","author":"SM Ahmad","year":"2016","unstructured":"Ahmad, S. M., Borch, T. H., Hansen, M. & Andersen, M. H. PD-L1-specific T cells. Cancer Immunol. Immunother. 65, 797\u2013804 (2016).","journal-title":"Cancer Immunol. Immunother."},{"key":"10009_CR17","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.1016\/j.ymthe.2024.09.026","volume":"32","author":"D Lee","year":"2024","unstructured":"Lee, D., Cho, M., Kim, E., Seo, Y. & Cha, J. H. PD-L1: from cancer immunotherapy to therapeutic implications in multiple disorders. Mol. Ther. 32, 4235\u20134255 (2024).","journal-title":"Mol. Ther."},{"key":"10009_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13046-016-0458-0","volume":"35","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. et al. Hyaluronan synthase 2 expressed by cancer-associated fibroblasts promotes oral cancer invasion. J. Exp. Clin. Cancer Res. 35, 181 (2016).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10009_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/cr.2016.39","volume":"26","author":"KN Swatek","year":"2016","unstructured":"Swatek, K. N. & Komander, D. Ubiquitin modifications. Cell Res. 26, 399\u2013422 (2016).","journal-title":"Cell Res."},{"key":"10009_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.nbd.2010.08.001","volume":"43","author":"KL Lim","year":"2011","unstructured":"Lim, K. L. & Lim, G. G. K63-linked ubiquitination and neurodegeneration. Neurobiol. Dis. 43, 9\u201316 (2011).","journal-title":"Neurobiol. Dis."},{"key":"10009_CR21","doi-asserted-by":"publisher","unstructured":"Tracz, M. & Bialek, W. Beyond K48 and K63: non-canonical protein ubiquitination. Cell Mol. Biol. Lett. 26, https:\/\/doi.org\/10.1186\/s11658-020-00245-6 (2021).","DOI":"10.1186\/s11658-020-00245-6"},{"key":"10009_CR22","doi-asserted-by":"publisher","unstructured":"Kim, E. A. et al. Potential skin health benefits of abalone by-products suggested by their effects on MAPKS and PI3K\/AKT\/NF-kB signaling pathways in HDF and HaCaT cells. Foods 13, https:\/\/doi.org\/10.3390\/foods13182902 (2024).","DOI":"10.3390\/foods13182902"},{"key":"10009_CR23","doi-asserted-by":"publisher","first-page":"42349","DOI":"10.1074\/jbc.M111.278598","volume":"286","author":"B Bernert","year":"2011","unstructured":"Bernert, B., Porsch, H. & Heldin, P. Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1). J. Biol. Chem. 286, 42349\u201342359 (2011).","journal-title":"J. Biol. Chem."},{"key":"10009_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","volume":"18","author":"MH Sherman","year":"2023","unstructured":"Sherman, M. H. & Beatty, G. L. Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance. Annu. Rev. Pathol. 18, 123\u2013148 (2023).","journal-title":"Annu. Rev. Pathol."},{"key":"10009_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.971278","volume":"13","author":"W Donelan","year":"2022","unstructured":"Donelan, W., Dominguez-Gutierrez, P. R. & Kusmartsev, S. Deregulated hyaluronan metabolism in the tumor microenvironment drives cancer inflammation and tumor-associated immune suppression. Front. Immunol. 13, 971278 (2022).","journal-title":"Front. Immunol."},{"key":"10009_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","volume":"17","author":"AN Hosein","year":"2020","unstructured":"Hosein, A. N., Brekken, R. A. & Maitra, A. Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat. Rev. Gastroenterol. Hepatol. 17, 487\u2013505 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10009_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8861766","volume":"2021","author":"M Yu","year":"2021","unstructured":"Yu, M. et al. Increased SPHK1 and HAS2 expressions correlate to poor prognosis in pancreatic cancer. Biomed. Res. Int. 2021, 8861766 (2021).","journal-title":"Biomed. Res. Int."},{"key":"10009_CR28","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41420-022-01204-0","volume":"8","author":"L Cao","year":"2022","unstructured":"Cao, L., Liu, X., Zheng, B., Xing, C. & Liu, J. Role of K63-linked ubiquitination in cancer. Cell Death Discov. 8, 410 (2022).","journal-title":"Cell Death Discov."},{"key":"10009_CR29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1242\/jcs.183954","volume":"129","author":"M Akutsu","year":"2016","unstructured":"Akutsu, M., Dikic, I. & Bremm, A. Ubiquitin chain diversity at a glance. J. Cell Sci. 129, 875\u2013880 (2016).","journal-title":"J. Cell Sci."},{"key":"10009_CR30","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/nar\/gkac011","volume":"50","author":"X Zhu","year":"2022","unstructured":"Zhu, X. et al. TRIM21 suppresses CHK1 activation by preferentially targeting CLASPIN for K63-linked ubiquitination. Nucleic Acids Res. 50, 1517\u20131530 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10009-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10009-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10009-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:37:29Z","timestamp":1780612649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10009-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10009"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10009-1","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"764"}}